Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2013

Jun 6, 2013

29777_rns_2013-06-06_32da77bb-8919-42c3-b72f-9bec401dbd92.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Page 1 of 1

SEC FORM 4

SEC Form 4

FORM 4

==> picture [478 x 517] intentionally omitted <==

----- Start of picture text ----- FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION OMB APPROVALWashington, D.C. 20549OMB Number: 3235-0287Check this box if no longer subject to STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Expires: December 31, 2014Section 16. Form 4 or Form 5 Estimated average burdenobligations may continue. Instruction 1(b). See Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934or Section 30(h) of the Investment Company Act of 1940 hours per response: 0.51. Name and Address of Reporting Person [*] 2. Issuer Name and Ticker or Trading Symbol 5. Relationship of Reporting Person(s) to IssuerALBAN CARLOS ABBOTT LABORATORIES [ ABT ] (Check all applicable)Director 10% OwnerX Officer (give title Other (specify3. Date of Earliest Transaction (Month/Day/Year) below) below)(Last) (First) (Middle)02/18/2011 Senior Vice President100 ABBOTT PARK ROAD4. If Amendment, Date of Original Filed (Month/Day/Year) 6. Individual or Joint/Group Filing (Check Applicable(Street) Line)ABBOTT X Form filed by One Reporting PersonIL 60064PARK Form filed by More than One ReportingPerson(City) (State) (Zip)Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned1. Title of Security (Instr. 3) 2. Transaction 2A. Deemed 3. 4. Securities Acquired 5. Amount of 6. 7. NatureDate Execution Date, Transaction (A) or Disposed Of (D) Securities Ownership of Indirect(Month/Day/Year) if any Code (Instr. (Instr. 3, 4 and 5) Beneficially Form: Beneficial(Month/Day/Year) 8) Owned Direct (D) or OwnershipFollowing Indirect (I) (Instr. 4)(A) Reported (Instr. 4)Code V Amount or Price Transaction(s)(D) (Instr. 3 and 4)Common shares without par value 02/18/2011 A 32,500(1) A $ 0 98,273 DProfitCommon shares without par value 660 [(2)] I Sharing Trust(U.S.)ProfitSharingCommon shares without par value 135 [(2)] I Trust(PuertoRico)Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned(e.g., puts, calls, warrants, options, convertible securities)1. Title of 2. 3. Transaction 3A. Deemed 4. 5. Number 6. Date Exercisable and 7. Title and Amount 8. Price of 9. Number 10. 11. NatureDerivative Conversion Date Execution Date, Transaction of Expiration Date of Securities Derivative of Ownership of IndirectSecurity or Exercise (Month/Day/Year) if any Code (Instr. Derivative (Month/Day/Year) Underlying Security derivative Form: Beneficial(Instr. 3) Price of (Month/Day/Year) 8) Securities Derivative Security (Instr. 5) Securities Direct (D) OwnershipDerivative Acquired (Instr. 3 and 4) Beneficially or Indirect (Instr. 4)Security (A) or Owned (I) (Instr. 4)Disposed Followingof (D) Reported(Instr. 3, 4 Transactionand 5) (s) (Instr. 4)AmountorNumberDate Expiration ofCode V (A) (D) Exercisable Date Title SharesOption Common(right to buy) [(3)] $ 46.6 02/18/2011 A 45,800 02/18/2012 02/17/2021 shares 45,800 $ 0 45,800 DExplanation of Responses:----- End of picture text -----

  1. These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

  2. Balance in the Abbott Laboratories Stock Retirement Trust as of February 18, 2011.

  3. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 15,267 on 02/18/2012, 15,266 on 02/18/2013, and 15,267 on 02/18/2014. John A. Berry, by power of 02/23/2011 attorney for Carlos Alban ** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

  • If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

  • ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

http://www.sec.gov/Archives/edgar/data/1800/000117911011003273/xslF345X03/ed...

30/05/2013